Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pichler

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 31, 2017
Long-term cardiovascular complications in stage I seminoma patientsA Terbuch, F Posch, L M Annerer, et al.
Wiener Klinische Wochenschrift|October 8, 1999
[Secondary prevention following coronary intervention. Survey of 13 intervention centers in Austria]H Drexel, G B Gaul, G Grimm, et al.
Der Radiologe|October 29, 2021
[Rare soft tissue tumour of the skin of the chest]A Ruiu, S Stuppner, M Barillari, et al.
The Pharmacogenomics Journal|February 11, 2015
LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapyJ Szkandera, S Herzog, M Pichler, et al.
British Journal of Cancer|February 8, 2014
MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patientsM Pichler, A L Ress, E Winter, et al.
British Journal of Cancer|November 9, 2013
Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patientsJ Szkandera, M Stotz, G Absenger, et al.
British Journal of Cancer|June 27, 2013
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancerM Stotz, A Gerger, F Eisner, et al.
Nature|March 19, 2026
Adventitious carbon breaks symmetry in oxide contact electrificationGalien Grosjean, Markus Ostermann, Markus Sauer, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 17, 2020
Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapyS Mollnar, P Pondorfer, A-K Kasparek, et al.
Bioorganic & Medicinal Chemistry|November 3, 2022
Targeting osteoarthritis-associated galectins and an induced effector class by a ditopic bifunctional reagent: Impact of its glycan part on binding measured in the tissue contextJoachim C Manning, Veronica Baldoneschi, Laura L Romero-Hernández, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 31, 2017
Long-term cardiovascular complications in stage I seminoma patientsA Terbuch, F Posch, L M Annerer, et al.
Wiener Klinische Wochenschrift|October 8, 1999
[Secondary prevention following coronary intervention. Survey of 13 intervention centers in Austria]H Drexel, G B Gaul, G Grimm, et al.
Der Radiologe|October 29, 2021
[Rare soft tissue tumour of the skin of the chest]A Ruiu, S Stuppner, M Barillari, et al.
The Pharmacogenomics Journal|February 11, 2015
LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapyJ Szkandera, S Herzog, M Pichler, et al.
British Journal of Cancer|February 8, 2014
MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patientsM Pichler, A L Ress, E Winter, et al.
British Journal of Cancer|November 9, 2013
Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patientsJ Szkandera, M Stotz, G Absenger, et al.
British Journal of Cancer|June 27, 2013
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancerM Stotz, A Gerger, F Eisner, et al.
Nature|March 19, 2026
Adventitious carbon breaks symmetry in oxide contact electrificationGalien Grosjean, Markus Ostermann, Markus Sauer, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 17, 2020
Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapyS Mollnar, P Pondorfer, A-K Kasparek, et al.
Bioorganic & Medicinal Chemistry|November 3, 2022
Targeting osteoarthritis-associated galectins and an induced effector class by a ditopic bifunctional reagent: Impact of its glycan part on binding measured in the tissue contextJoachim C Manning, Veronica Baldoneschi, Laura L Romero-Hernández, et al.
Pageof 19